Development of human antibody fragments using antibody phage display for the detection and diagnosis of Venezuelan equine encephalitis virus (VEEV)

BMC Biotechnology

Volumn 8, Issue , 2008, Pages

  Kirsch, Martina Inga ^a   Hülseweh, Birgit ^b   Nacke, Christoph ^a   Rülker, Torsten ^a   Schirrmann, Thomas ^a   Marschall, Hans Jürgen ^b   Hust, Michael ^a   Dübel, Stefan ^a  

^a TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

^b Armed Forces Scientific Institute for NBC Protection   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; CHLORINE COMPOUNDS; FORMALDEHYDE; VIRUSES;

ANTIBODY FRAGMENTS; ANTIBODY GENES; BIO-TERRORISM; BIOLOGICAL WARFARE; CHAIN FRAGMENTS; CROSS REACTIVITIES; DETECTION REAGENTS; FORMALIN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL DETECTION; INFECTED CELLS; PHAGE CLONES; PHAGE DISPLAYS; RECOMBINANT ANTIBODIES; SELECTION PROCESSES; SPECIFIC DETECTION; VIRUS PARTICLES; WESTERN-BLOT ANALYSIS;

COMPUTER VIRUSES;

FORMALDEHYDE; RECOMBINANT ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; VIRUS PROTEIN; IMMUNOGLOBULIN FRAGMENT; PEPTIDE LIBRARY;

ANTIBODY ISOLATION; ARTICLE; BIOLOGICAL WARFARE; CHIKUNGUNYA ALPHAVIRUS; CLONE; CONTROLLED STUDY; CROSS REACTION; EASTERN EQUINE ENCEPHALOMYELITIS VIRUS; GENE LIBRARY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PHAGE DISPLAY; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS; VERO CELL; VIRUS DETECTION; VIRUS PARTICLE; VIRUS STRAIN; WESTERN BLOTTING; BIOASSAY; GENETIC PROCEDURES; IMMUNOASSAY; IMMUNOLOGY; ISOLATION AND PURIFICATION; METHODOLOGY;

ALPHAVIRUS; CHIKUNGUNYA VIRUS; EASTERN EQUINE ENCEPHALITIS VIRUS; VENEZUELAN EQUINE ENCEPHALITIS VIRUS; WESTERN EQUINE ENCEPHALOMYELITIS VIRUS;

BIOLOGICAL ASSAY; BIOSENSING TECHNIQUES; ENCEPHALITIS VIRUS, VENEZUELAN EQUINE; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN FRAGMENTS; PEPTIDE LIBRARY;

EID: 52449088919     PISSN: None     EISSN: 14726750     Source Type: Journal    
DOI: 10.1186/1472-6750-8-66     Document Type: Article

References (57)

1. Kubes V Rios FA The causative agent of infectious equine encephalomytitis in Venezuela Science 1939, 90(2323):20-21. 17818578
2. Powers AM Brault AC Shirako Y Strauss EG Kang W Strauss JH Weaver SC Evolutionary Relationships and Systematics of the Alphaviruses J Virol 2001, 75:10118-10131. 114586 11581380
3. Strauss JH Strauss EG The alphaviruses: Gene expression, replication, and evolution Microbiol Rev 1994, 58:491-562. 372977 7968923
4. Johnson KM Martin DH Venezuelan equine encephalitis Advances in the veterinary science and comparitive medicine New York and London: Academic Press Brandley CA, Cornelius CE 1974, 79-116.
5. Hawley RJ Eitzen EM Biological weapons - a primer for microbioligist Annu Rev Microbiol 2001, 55:235-253. 11544355
6. Powers AM Oberste MS Brault AC Rico-Hesse R Schmura SM Smith JF Kang W Sweeney WP Weaver SC Repeated emergence of epidemic/epizootic Venezuelan equine encephalitis from a single genotype of enzootic subtype ID virus J Virol 1997, 71:6697-6705. 191949 9261393
7. Weaver SC Salas R Rico-Hesse R Ludwig GV Oberste MS Boshell J Tesh RB Re-emergence of epidemic Venezuelan equine encephalomyelitis in South America. VEE Study Group Lancet 1996, 348:436-440. 8709783
8. Sanchez JL Takafuji ET Lednar WM LeDuc JW Macasaet FF Mangiafico JA Rosato RR Driggers DP Haecker JC Venezuelan equine encephalomyelitis: Report of an outbreak associated with jungle exposure Mil Med 1984, 149:618-621. 6438552
9. Sudia WD Newhouse VF Beadle ID Miller DL Johnston JG Jr Young R Calisher CH Maness K Epidemic Venezuelan equine encephalitis in North America in 1971: Vector studies Am J Epidemiol 1975, 101:17-35. 235212
10. Franck P Round table on epidemic control Venezuelan Encephalitis Pan American Health Organization. Washington DC 1972, 243:400-401.
11. Rivas F Diaz LA Cardenas VM Daza E Bruzon L Alcala A De la Hoz O Canceres FM Aristizabal G Martinez JW Revelo D De la Hoz F Boshell J Camacho T Calderon L Olano VA Villareal LI Roselli D Alvarez G Ludwig G Tsai T Epidemic Venezuelan equine encephalitis in La Guajira Colombia, 1995 J Infect Dis 1997, 175(4):828-832. 9086137
12. Leitenberg M Biological Weapons in the Twentieth Century: A Review and Analysis Crit Rev Microbiol 2001, 27(4):267-320. 11791799
13. Hoke CH History of U.S. Military Contributions to the Study of viral Encephalitis Military Medicine 2005, 170:92-105. 15916288
14. Reed DS Lind CM Sullivan LJ Pratt WD Parker MD Aerosol Infection of Cynomolgus Macaques with Enzootic Strains of Venezuelan Equine Encephalitis Viruses J Infect Dis 2004, 189(6):1013-1017. 14999604
15. Johnstone RE Peters CJ Alphaviruses Fields virology Philadelphia, New York: Lippincott-Raven Fields BN, Knipe DM, Howley PM 3, 1995:843-898.
16. Smith JF Davis K Hart MK Ludwig GV McClain DJ Parker MD Pratt WD Viral encephalitides Textbook of Military Medicine; Medical Aspects of Chemical and Biological Warfare Washington DC: Office of surgeon general 1997, 561-589.
17. Blue Book, Sixth Edition, April 2005. US Army Medical Research Institute of Infectious Disease (USAMRIID), Published by USAMRIID, the lead medical research laboratory for the US Biological Defense Research Program http://www.usamriid.army.mil/education/instruct.htm
18. McCafferty J Griffiths AD Winter G Chiswell DJ Phage antibodies: filamentous phage displaying antibody variable domain Nature 1990, 348:552-554. 2247164
19. Breitling F Dübel S Seehaus T Kleewinghaus I Little M A surface expression vector for antibody screening Gene 1991, 104:1047-153.
20. Clackson T Hoogenboom HR Griffiths AD Winter G Making antibody fragments using phage display libraries Nature 1991, 352:624-628. 1907718
21. Hoogenboom HR Griffiths AD Johnson KS Chiswell DJ Hudson P Winter G Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains Nucl Acids Res 1991, 19:4133-4137. 328552 1908075
22. Better M Chang CP Robinson RR Horwitz AH Escherichia coli secretion of an active chimeric antibody fragment Science 1988, 240:1041-1043. 3285471
23. Huston JS Levinson D Mudgett HM Tai MS Novotny J Margolies MN Ridge RJ Bruccoloreri RE Haber E Crea R Oppermann H Protein engineering of antibody binding sites: Recovery of specific activity in an anti-digosin single-chain Fv analogue produced in Escherichia coli Proc Natl Acad Sci USA 1988, 85:5879-5883. 281868 3045807
24. Konthur Z Hust M Dübel S Perspectives for systematic in vitro antibody generation Gene 2005, 364(19):29. 16126351
25. Hust M Dübel S Schirrmann T Selection of recombinant antibodies from antibody gene libraries Methods Mol Biol 2007, 408:243-255. 18314587
26. Brink Van den EN Ter Meulen J Cox F Jongeneelen MA Thijsse A Throsby M Marissen WE Rood PM Bakker AB Gelderblom HR Martina BE Osterhaus AD Preiser W Doerr HW de Kruif J Goudsmit J Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus J Virol 2005, 79:1635-1644. 544131 15650189
27. Rodriguez-Diaz J Monedero V Perez-Martinez G Buesa J Single-chain variable fragment (scFv) antibodies against rotavirus NSP4 enterotoxin generated by phage display J Virol Methods 2004, 121(2):231-238. 15381361
28. Donà MG Giorgi C Accardi L Characterization of antibodies in single-chain format against the E7 oncoprotein of the human papillomavirus type 16 and their improvement by mutagenesis BMC Cancer 2007, 7:25. 1797048 17266749
29. Velappan N Martinez JS Valero R Chasteen L Ponce L Bondu-Hawkins V Kelly C Pavlik P Hjelle B Bradbury AR Selection and characterization of scFv antibodies against the Sin Nombre hantavirus nucleocapsid protein J Immunol Methods 2007, 321(1-2);60-69. 17336997
30. De Carvalho NC Williamson RA Parren PW Lundkvist A Burton DR Bjöhrling E Neutralizing human Fab fragments against measles virus recovered by phage display J Virol 2002, 76:251-258. 135717 11739690
31. Koch J Liang M Queitsch I Kraus AA Bautz EKF Human recombinant neutralizing antibodies against Hantaan virus G2 protein Virology 2003, 308:64-73. 12706090
32. Duan J Ji X Feng J Han W Zhang P Cao W Guo X Qi C Yang D Jin G Gao G Yan X A human neutralizing antibody against a conformational epitope shared by oligomeric SARS S1 protein Antivir Ther 2006, 11:117-123. 16518967
33. Calisher CH Karabatsos N Lazuick JS Monath TP Wolff KL Reevaluation of the western equine encephalitis antigenic complex of alphaviruses(family Togaviridae) as determined by neutralization tests Am J Trop Med Hyg 1988, 38:447-52. 2833129
34. Nagata LP Hu WG Parker M Chau D Rayner GA Schmaltz FL Wong JP Infectivity variation and genetic diversity among strains of Western equine encephalitis virus J Gen Virol 2006, 87:2353-2361. 16847131
35. Greiser-Wilke IM Moennig M Kaaden OR Shope R Detection of alphaviruses in a genus-specific antigen capture enzyme immunoassay using monoclonal antibodies J Clin Microbiol 1991, 29:131-137. 269716 1847149
36. Mathews JJ Roehrig JT Determination of the protective epitopes on the glycoproteins of Venezuelan equine encephalomyelitis virus by passive transfer of monoclonal antibodies J Immunol 1982, 129:2763-2767. 6183343
37. Roehrig JT Hunt AR Kinney RM Mathews JH In vitro mechanisms of monoclonal antibody neutralization of alphaviruses Virology 1988, 165:66-73. 2455383
38. Hunt AR Roehrig JT Localization of a protective epitopeon a Venezuelan equine encephalomyelitis (VEE) virus peptide that protects mice from both epizootic and enzootic VEE virus challengeand is immunogenic in horses Vaccine 1995, 13:281-288. 7543231
39. Hunt AR Frederickson S Hinkel C Bowdish KS Roehrig JT A humanized murine monoclonal antibody protects mice either before or after challenge with virulent Venezuelan equine encephalomyelitis virus J Gen Virol 2006, 87:2467-2476. 16894184
40. Roehrig JT Mathews JH The neutralization site on the E2glycoprotein of Venezuelan equine encephalomyelitis (TC-83) virus is composed of multiple conformationally stable epitopes Virology 1985, 142:347-356. 2414905
41. Wang E Paessler S Aguilar PV Smith DR Coffey LL Kang W Pfeffer M Olson J Blair PJ Guevara C Estrada-Franco J Weaver SC A novel, rapid assay for detection and differentiation of serotype-specific antibodies to Venezuelan equine encephalitis complex alphaviruses Am J Trop Med Hyg 2005, 72:805-810. 15964967
42. Duggan JM Coates DM Ulaeto DO Isolation of single-chain antibody fragments against venezualan equine encephalomyelitis virus from two different immune sources Viral Immunol 2001, 14:263-273. 11572636
43. Guo YC Zhou YF Zhang XE Zhang ZP Qiao YM Bi LJ Wen JK Liang MF Zhang JB Phage display mediated immuno-PCR Nucleic Acids Res 2006, 34:e62. 1458518 16682441
44. Spearman C The method of right and wrong cases (constat stimuli) without Gauss formulae Brit J Psychol 1908, 2:227-242.
45. Kaerber G Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche Arch Exp Pathol Pharmakol 1931, 162:480-483.
46. Berge TO Banks IS Tiggert WD Attenuation of Venezuelan equine encephalomyelitis virus by in vitro cultivation in guinea-pig heart cells American Journal of Hygiene 1961, 73:209-218.
47. Frolov IV Kolykhalov AA Volchakov VE Netesov SV Sandakhchiev LS Comparison of the amino acid sequence of structural proteins from attenuated and pathogenic strains of the Venezuelan equine encephalomyelitis virus Dokl Akad Nauk SSSR 1991, 318:1488-1491. 1914828
48. Sambrook J Russell DW (Eds) Molecular cloning: A laboratory manual New York: Cold Spring Harbor Laboratory Press 3, 2001.
49. Hust M Toleikis L Dübel S Antibody phage display Handbook of therapeutic antibodies Weinheim: Willey-VCH Dübel S 2007, 45-68.
50. Pelat T Hust M Laffly E Condemine F Bottex C Vidal D Lefranc MP Dübel S Thullier P A high affinity, human like antibody fragment (scFv) neutralising lethal factor (LF) of Bacillus anthracis by inhibiting the PA-LF complex formation Antimicro Agents Chem 2007, 51:2758-2764.
51. Rondot S Koch J Breitling F Dübel S A helper phage to improve single-chain antibody presentation in phage display Nat Biotechnol 2001, 19(1):75-78. 11135557
52. Hust M Meysing M Schirrmann T Selke M Meens J Gerlach GF Dübel S Enrichment of open reading frames presented on bacteriophage M13 using Hyperphage Biotechniques 2006, 41:335-342. 16989094
53. Soltes G Hust M Ng KKY Bansal A Field J Stewart DIH Dübel S Cha S Wiersma E On the influence of vector design on antibody phage display J Biotechnol 2007, 127(4):626-237. 1866265 16996161
54. Retter I Althaus HH Münch R Müller W VBASE2, an integrative V gene database Nucleic Acids Res 2005, 33(Database issue):D671-D674. 540042 15608286
55. Mollova S Retter I Müller W Visualising the immune repertoire BMC Systems Biology 2007, 1:P30.
56. Kirsch M Zaman M Meier D Dübel S Hust M Parameters affecting the display of antibodies on phage J Immunol Methods 2005, 301(1-2):173-185. 15992816
57. Li J Menzel C Meier D Zhang C Dübel S Jostock T A comparative study of different vector designs for the mammalian expression of recombinant IgG antibodies J Immunol Methods 2007, 318(1-2):113-124. 17161420